KoBioLabs, Inc (KOSDAQ:348150)

KoBioLabs Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 19, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	95,638	103,844	160,602	191,231	335,174	672,727
Market Cap Growth	-5.07%	-35.34%	-16.02%	-42.95%	-50.18%	-
Enterprise Value	77,441	80,193	121,886	127,584	294,643	650,116
Last Close Price	4925.00	5360.00	8510.00	11050.00	20600.00	43350.00
PS Ratio	1.33	1.52	4.85	16.48	115.84	146.52
PB Ratio	1.91	1.87	2.60	2.00	3.70	12.15
P/TBV Ratio	3.00	2.79	3.65	2.51	3.75	12.21
EV/Sales Ratio	1.08	1.17	3.68	10.99	101.84	141.59
Debt / Equity Ratio	0.28	0.30	0.30	0.14	0.10	0.00
Net Debt / Equity Ratio	-0.71	-0.71	-0.78	-0.83	-0.88	-0.92
Net Debt / EBITDA Ratio	6.42	9.08	2.83	4.08	4.94	4.19
Net Debt / FCF Ratio	5.09	6.55	1.66	2.53	4.42	3.95
Asset Turnover	0.73	0.63	0.28	0.10	0.04	0.10
Inventory Turnover	3.87	7.27	7.72	5.88	5.50	17.11
Quick Ratio	4.19	4.28	3.36	10.95	13.45	18.17
Current Ratio	4.78	4.82	3.58	11.46	14.42	18.71
Return on Equity (ROE)	-12.04%	-7.87%	-19.28%	-25.14%	-21.07%	-1173.43%
Return on Assets (ROA)	-5.24%	-3.98%	-9.67%	-11.07%	-12.47%	-16.44%
Return on Capital Employed (ROCE)	-10.30%	-7.80%	-19.70%	-17.60%	-16.60%	-22.30%
Earnings Yield	-6.85%	-5.10%	-8.63%	-11.46%	-4.59%	-8.19%
FCF Yield	-7.31%	-5.77%	-18.04%	-16.34%	-5.37%	-1.92%
Buyback Yield / Dilution	-1.42%	-3.54%	-10.30%	-4.68%	-49.69%	-51.75%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.